Journal of Headache and Pain

Papers
(The TQCC of Journal of Headache and Pain is 19. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II392
Is there a causal relationship between stress and migraine? Current evidence and implications for management200
Interleukin-6 induces spatially dependent whole-body hypersensitivity in rats: implications for extracephalic hypersensitivity in migraine136
Post-traumatic trigeminal neuropathy: correlation between objective and subjective assessments and a prediction model for neurosensory recovery97
Efficacy and safety of fremanezumab in patients with episodic and chronic migraine with documented inadequate response to 2 to 4 classes of migraine preventive medications over 6 months of treatment i91
Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension79
The International Headache Congress – IHS and EHF joint congress 2021: late breaking abstracts78
Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database73
Shift from high-frequency to low-frequency episodic migraine in patients treated with Galcanezumab: results from two global randomized clinical trials68
Development and validation of a novel model for characterizing migraine outcomes within real-world data60
Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis59
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study56
Migraine patients in Germany - need for medical recognition and new preventive treatments: results from the PANORAMA survey53
Altered effective connectivity in migraine patients during emotional stimuli: a multi-frequency magnetoencephalography study52
Enhanced functional connectivity between habenula and salience network in medication-overuse headache complicating chronic migraine positions it within the addiction disorders: an ICA-based resting-st50
Altered speech patterns in subjects with post-traumatic headache due to mild traumatic brain injury44
Episodic headache with spontaneous hypothermia reveal Shapiro’s syndrome variant with effectiveness of clonidine therapy43
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance43
Tracking tDCS induced grey matter changes in episodic migraine: a randomized controlled trial42
Osmophobia in primary headache patients: associated symptoms and response to preventive treatments41
Interictal osmophobia is associated with longer migraine disease duration40
MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention40
Effect of dural inflammatory soup application on activation and sensitization markers in the caudal trigeminal nucleus of the rat and the modulatory effects of sumatriptan and kynurenic acid38
Role of CGRP pathway polymorphisms in migraine: a systematic review and impact on CGRP mAbs migraine therapy38
Deterioration of headache impact and health-related quality of life in migraine patients after cessation of preventive treatment with CGRP(−receptor) antibodies37
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience37
Selective denervation of the corrugator supercilii muscle for the treatment of idiopatic trigeminal neuralgia purely paroxysmal distributed in the supraorbital and suprathrochlear dermatomes37
Repeated oxytocin prevents central sensitization by regulating synaptic plasticity via oxytocin receptor in a chronic migraine mouse model37
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis36
Altered functional connectivity of the right caudate nucleus in chronic migraine: a resting-state fMRI study35
Sphingosine-1 phosphate receptor 1 contributes to central sensitization in recurrent nitroglycerin-induced chronic migraine model34
Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study34
Long term evaluation of a multidisciplinary trigeminal neuralgia service34
Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache33
CGRP-dependent sensitization of PKC-δ positive neurons in central amygdala mediates chronic migraine32
HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism30
In search of a gold standard patient-reported outcome measure to use in the evaluation and treatment-decision making in migraine prevention. A real-world evidence study30
The economic and personal burden of cluster headache: a controlled cross-sectional study29
Association between migraine and cognitive impairment29
Whole-brain morphological alterations associated with trigeminal neuralgia29
Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition28
Resting-state magnetoencephalographic oscillatory connectivity to identify patients with chronic migraine using machine learning27
Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description27
Functional correlation of ATP1A2 mutations with phenotypic spectrum: from pure hemiplegic migraine to its variant forms27
Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months26
Identification of disease- and headache-specific mediators and pathways in migraine using blood transcriptomic and metabolomic analysis26
The chronobiology of migraine: a systematic review25
Cerebral perfusion variance in new daily persistent headache and chronic migraine: an arterial spin-labeled MR imaging study25
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update24
Correction to: Migraine-relevant sex-dependent activation of mouse meningeal afferents by TRPM3 agonists24
Altered amygdala effective connectivity in migraine without aura: evidence from resting‐state fMRI with Granger causality analysis24
Correction to: Burden of migraine and unmet needs from the patients’ perspective: a survey across 11 specialized headache clinics in Korea24
The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients24
Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education for patients with tension-type headache. A systematic review and meta-ana23
Burden of tension-type headache in the Middle East and North Africa region, 1990-201923
Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials23
Correction to: CGRP induces migraine-like symptoms in mice during both the active and inactive phases23
Migraine-relevant sex-dependent activation of mouse meningeal afferents by TRPM3 agonists23
Insular functional connectivity in migraine with aura22
Avoid or seek light – a randomized crossover fMRI study investigating opposing treatment strategies for photophobia in migraine22
Effectiveness and acceptability of noninvasive brain and nerve stimulation techniques for migraine prophylaxis: a network meta-analysis of randomized controlled trials22
Metabolic profile changes in serum of migraine patients detected using 1H-NMR spectroscopy22
Hemicrania continua associated with an unruptured anterior communicating artery aneurysm: first case report22
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study21
Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study21
PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine21
Time is of the essence in headache measurement. A response to Gil-Gouveia21
Investigation of cortical thickness and volume during spontaneous attacks of migraine without aura: a 3-Tesla MRI study21
Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors?21
De novo headache in ischemic stroke patients treated with thrombectomy: a prospective study20
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study20
Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A220
The sensitivity to change of the cluster headache quality of life scale assessed before and after deep brain stimulation of the ventral tegmental area20
InterMiG: international differences in the therapeutic approach to migraine patients in specialized headache centers19
Psychological predictors of negative treatment outcome with Erenumab in chronic migraine: data from an open label long-term prospective study19
Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation19
Differences in gray matter volume in episodic migraine patients with and without prior diagnosis or clinical care: a cross-sectional study19
Measuring dose-related efficacy of eptinezumab for migraine prevention: post hoc analysis of PROMISE-1 and PROMISE-219
Age-related differences in resting state functional connectivity in pediatric migraine19
Association between suicidal risks and medication-overuse headache in chronic migraine: a cross-sectional study19
The bidirectional temporal relationship between headache and affective disorders: longitudinal data from the HUNT studies19
Petasin and isopetasin reduce CGRP release from trigeminal afferents indicating an inhibitory effect on TRPA1 and TRPV1 receptor channels19
The relationship between headache-attributed disability and lost productivity: 2. Empirical evidence from population-based studies in nine disparate countries19
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study19
Angioarchitectural features amongst patients with unruptured brain arteriovenous malformations presenting with headache: findings from a single center retrospective review of 76 patients19
Pre-attack and pre-episode symptoms in cluster headache: a multicenter cross-sectional study of 327 Chinese patients19
The applicability research of the diagnostic criteria for 6.7.2 angiography headache in the international classification of headache disorders-3rd edition19
0.090050935745239